Pontifax Funds
Investor profile
Investment firmVenture capital
Also recorded as: Pontifax · Pontifax Venture Capital
Deals
11
distinct rounds
Companies
11
backed
Active span
2016–2023
8 yrs
Total round €
€522M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Forbion2
- Novo Holdings2
- Pfizer Ventures2
- TriVentures2
- Andera Partners1
- Aperture Capital1
- Arkin Holdings1
- ATEM1
- BioMedPartners1
- BioStar Ventures1
- Boehringer Ingelheim Venture Fund1
- BRM Capital1
- Cowen Healthcare Investments1
- Crédit Agricole Création1
- CTI Life Sciences1
- Deerfield1
- Edwards Lifesciences1
- Endeavour Vision1
- EQT Life Sciences1
- Gauss Medical1
- GIMV1
- HealthCap1
- INKEF Capital1
- Innobio 21
- Intermediate Capital Group1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Amolyt Pharma | France | 1 | €129M |
| Anaveon | Switzerland | 1 | €106M |
| Emergence Therapeutics | Germany | 1 | €87M |
| Precirix | Belgium | 1 | €80M |
| V-Wave | Israel | 1 | €60M |
| raziel therapeutics | Israel | 1 | €19M |
| Metabomed | Israel | 1 | €16M |
| Eyevensys | France | 1 | €9.0M |
| EyeYon Medical | Israel | 1 | €6.5M |
| TargEDys | France | 1 | €5.8M |
| Sweetch | Israel | 1 | €3.2M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Amolyt Pharma | Series C | €129M | 2023-01 |
| Anaveon | Series B | €106M | 2021-12 |
| Emergence Therapeutics | Other | €87M | 2021-12 |
| Precirix | Series B | €80M | 2022-03 |
| V-Wave | Other | €60M | 2018-01 |
| raziel therapeutics | Series C | €19M | 2019-09 |
| Metabomed | Series A | €16M | 2016-03 |
| Eyevensys | Series A | €9.0M | 2016-08 |
| EyeYon Medical | Series B | €6.5M | 2017-02 |
| TargEDys | Series A | €5.8M | 2016-03 |